Eli Lilly & Co.
Symbol: LLY (NYSE)
760.00
▼ (-0.39%) -3.000
Company Description:
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Key Stats
- Today's Open: $756.7
- Today's High: $762
- Today's Low: $754.28
- Today's Volume: 16.52K
- Yesterday Close: $763
- Yesterday High: $766.3499
- Yesterday Low: $725.3101
- Yesterday Volume: 6.23M
- Last Min Volume: 22
- Last Min High: $760
- Last Min Low: $760
- Last Min VWAP: $760
Company Profile
- Name: Eli Lilly & Co.
- Website: https://www.lilly.com
- Listed Date: 1970-07-09
- Location: INDIANAPOLIS, IN
- Market Status: Active
- CIK Number: 0000059478
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $684.00B
- Round Lot: 100
- Outstanding Shares: 896.46M
- Asset Type: CS
RECENT FILINGS FOR LLY
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-22 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-18 | 144 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-08-28 | 144 | View |
| 2025-08-28 | 4 | View |
| 2025-08-28 | 4 | View |
| 2025-08-20 | 8-K | View |
| 2025-08-19 | 424B2 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | FWP | View |
Latest News on LLY